Strata Skin Sciences
(OTC) SSKN
Strata Skin Sciences Financials at a Glance
Market Cap
$1.59M
Revenue (TTM)
$30.98M
Net Income (TTM)
$11.04M
EPS (TTM)
$-2.62
P/E Ratio
-0.10
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Price
$0.27
Volume
113,299
Open
$0.26
Price
$0.27
Volume
113,299
Open
$0.26
Previous Close
$0.27
Daily Range
$0.26 - $0.28
52-Week Range
$0.12 - $3.86
Dividend
$0.00
Beta (Volatility)
0.42 (Low)
Price
$0.27
Volume
113,299
Open
$0.26
Previous Close
$0.27
Daily Range
$0.26 - $0.28
52-Week Range
$0.12 - $3.86
SSKN News
3 Stocks Shaking the Market
SSKN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Strata Skin Sciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
106
CEO
Dolev Rafaeli, PhD, MBA
Website
www.strataskinsciences.comHeadquarters
Horsham, PA 19044, US
SSKN Financials
Key Financial Metrics (TTM)
Gross Margin
58%
Operating Margin
-33%
Net Income Margin
-36%
Return on Equity
-207%
Return on Capital
-66%
Return on Assets
-36%
Earnings Yield
-10.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.59M
Shares Outstanding
5.89M
Volume
113.30K
Short Interest
0.00%
Avg. Volume
462.64K
Financials (TTM)
Gross Profit
$19.08M
Operating Income
$9.26M
EBITDA
$2.84M
Operating Cash Flow
$188.00K
Capital Expenditure
$1.64M
Free Cash Flow
$1.45M
Cash & ST Invst.
$7.26M
Total Debt
$16.44M
Strata Skin Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.93M
-21.2%
Gross Profit
$4.18M
-21.2%
Gross Margin
60.38%
N/A
Market Cap
$1.59M
N/A
Market Cap/Employee
$15.00K
N/A
Employees
106
N/A
Net Income
$1.62M
+23.6%
EBITDA
$173.00K
+34.7%
Quarterly Fundamentals
Net Cash
$9.24M
+1.9%
Accounts Receivable
$3.50M
-21.1%
Inventory
$3.06M
+11.4%
Long Term Debt
$14.17M
-12.3%
Short Term Debt
$2.14M
+564.9%
Return on Assets
-35.94%
N/A
Return on Invested Capital
-65.82%
N/A
Free Cash Flow
$1.08M
-197.3%
Operating Cash Flow
$64.00K
+78.8%